Panacea Biotec Limited
₹357.7
INR+17.00(+4.99%)
As of November 14, 2024 10:00:00 AMLatest News
Nov 1, 2024
Panacea Biotec (NSE:PANACEABIO) delivers shareholders strong 19% CAGR over 5 years, surging 13% in the last week alone
Read full article
Oct 3, 2024
There's No Escaping Panacea Biotec Limited's (NSE:PANACEABIO) Muted Revenues Despite A 40% Share Price Rise
Read full article
Aug 19, 2024
Panacea Biotec Limited (NSE:PANACEABIO) Held Back By Insufficient Growth Even After Shares Climb 25%
Read full article
Aug 14, 2024
Panacea Biotec shares up 5% as phase-3 trial of India's first dengue vaccine 'DengiAll' begins
Read full article
Aug 13, 2024
Insiders still own 70% of Panacea Biotec Limited (NSE:PANACEABIO) despite recent sales
Read full article